Snjezana Dogan

19PUBLICATIONS
91CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nanoscale characterisationHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Dec 04, 2024
Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions.

Ying-Hsia Chu, Nora Katabi, Purvil Sukhadia

|Jul 22, 2024
Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non-Small-Cell Lung Cancer.

Arielle Elkrief, Meagan Montesion, Smruthy Sivakumar

|May 06, 2024
The histological spectrum and immunoprofile of head and neck NUT carcinoma: A multicentre series of 30 cases.

Kartik Viswanathan, Elan Hahn, Snjezana Dogan

|Mar 26, 2024
Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.

Ronald Ghossein, Nora Katabi, Snjezana Dogan

|Jan 22, 2024
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.

Yagiz A Aksoy, Bin Xu, Kartik Viswanathan

|Nov 27, 2023
FGFR1/2/3-rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high-risk HPV in the sinonasal tract.

Ying-Hsia Chu, Kerry Mullaney, Sara E DiNapoli

Pageof 4

Frequent Collaborators

11 joint publications

Bin Xu

3 joint publications

Kartik Viswanathan

2 joint publications

Marc Ladanyi

2 joint publications

Nadeem Riaz